As per corporate shareholdings filed for Jun-2024, people matching Sofinnova Ventures publicly holds 77 stocks with a net worth of over US$ 2.2 B.
These are shares held by Sofinnova Ventures as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Immunogen, Inc. | Sofinnova Ventures | 31.23 | 2,045,202 | 0.73% | 0.00 | 63.9 M | ||
| Reata Pharmaceuticals Inc - Ordinary Shares - Class A | Sofinnova Ventures | 172.36 | 322,471 | 0.85% | 0.00 | 55.6 M | ||
| Cymabay Therapeutics Inc | Sofinnova Ventures | 32.48 | 1,411,769 | 1.23% | 0.00 | 45.9 M | ||
| Karuna Therapeutics Inc | Sofinnova Ventures | 329.83 | 1,381,149 | 3.62% | 0.00 | 455.5 M | ||
| NuCana plc - ADR | Sofinnova Ventures | 0.05 | 4,684,120 | 8.27% | 0.00 | 234.2 K | ||
| Inhibrx Inc | Sofinnova Ventures | 22.12 | 1,302,645 | 2.49% | 0.00 | 28.8 M | ||
| ShockWave Medical Inc | Sofinnova Ventures | 0.00 | 35,000 | 0.09% | 0.00 | - | ||
| Fusion Pharmaceuticals Inc | Sofinnova Ventures | 0.00 | 157,172 | 0.18% | 0.00 | - | ||
| Alnylam Pharmaceuticals Inc | Sofinnova Ventures | 320.52 | 147,929 | 0.11% | 0.03 | 47.4 M | ||
| Bolt Biotherapeutics Inc | Sofinnova Ventures | 5.74 | 2,754,437 | 7.20% | -0.03 | 15.8 M | ||
| Dyne Therapeutics Inc | Sofinnova Ventures | 9.17 | 1,625,703 | 1.60% | -0.34 | 14.9 M | ||
| Pulmonx Corp | Sofinnova Ventures | 3.18 | 60,246 | 0.15% | NEW | 191.6 K | ||
| Inari Medical Inc | Sofinnova Ventures | 79.97 | 155,838 | 0.27% | 0.25 | 12.5 M | ||
| Roivant Sciences Ltd | Sofinnova Ventures | 11.48 | 1,868,412 | 0.25% | 0.12 | 21.4 M | ||
| Revolution Medicines Inc | Sofinnova Ventures | 38.42 | 455,099 | 0.27% | NEW | 17.5 M | ||
| Y-Mabs Therapeutics Inc | Sofinnova Ventures | 4.33 | 2,194,278 | 4.90% | -0.10 | 9.5 M | ||
| Achieve Life Sciences Inc. | Sofinnova Ventures | 2.66 | 1,388,372 | 4.04% | -0.38 | 3.7 M | ||
| Align Technology, Inc. | Sofinnova Ventures | 189.02 | 218,524 | 0.29% | 0.16 | 41.3 M | ||
| Amylyx Pharmaceuticals Inc | Sofinnova Ventures | 8.21 | 299,691 | 0.44% | -0.01 | 2.5 M | ||
| Ascendis Pharma A/S - ADR | Sofinnova Ventures | 168.02 | 734,284 | 1.23% | -0.09 | 123.4 M | ||
| Astria Therapeutics Inc | Sofinnova Ventures | 6.26 | 60,692 | 0.11% | NEW | 379.9 K | ||
| ArriVent BioPharma Inc. | Sofinnova Ventures | 21.55 | 1,696,752 | 5.04% | -0.03 | 36.6 M | ||
| Jade Biosciences Inc | Sofinnova Ventures | 8.69 | 3,758,686 | 13.02% | -0.02 | 32.7 M | ||
| Avantor Inc. | Sofinnova Ventures | 12.34 | 141,045 | 0.02% | -0.01 | 1.7 M | ||
| Axonics Inc | Sofinnova Ventures | 70.98 | 150,490 | 0.29% | 0.00 | 10.7 M | ||
| Axsome Therapeutics Inc | Sofinnova Ventures | 109.68 | 310,198 | 0.64% | NEW | 34.0 M | ||
| Astrazeneca plc - ADR | Sofinnova Ventures | 68.72 | 801,417 | 0.03% | 0.01 | 55.1 M | ||
| Baxter International Inc. | Sofinnova Ventures | 27.37 | 117,769 | 0.02% | 0.02 | 3.2 M | ||
| Boston Scientific Corp. | Sofinnova Ventures | 103.78 | 171,080 | 0.01% | -0.01 | 17.8 M | ||
| Cabaletta Bio Inc | Sofinnova Ventures | 1.64 | 1,220,400 | 2.50% | 1.61 | 2.0 M | ||
| Celldex Therapeutics Inc. | Sofinnova Ventures | 22.06 | 547,707 | 0.83% | -0.38 | 12.1 M | ||
| Cogent Biosciences Inc | Sofinnova Ventures | 12.30 | 2,773,286 | 2.51% | 0.32 | 34.1 M | ||
| Dexcom Inc | Sofinnova Ventures | 84.03 | 61,494 | 0.02% | NEW | 5.2 M | ||
| Elanco Animal Health Inc | Sofinnova Ventures | 14.68 | 2,864,250 | 0.58% | 0.06 | 42.0 M | ||
| Erasca Inc | Sofinnova Ventures | 1.50 | 1,699,528 | 0.60% | NEW | 2.5 M | ||
| Establishment Labs Holdings Inc | Sofinnova Ventures | 42.60 | 429,244 | 1.53% | 1.03 | 18.3 M | ||
| Edwards Lifesciences Corp | Sofinnova Ventures | 76.56 | 724,225 | 0.12% | NEW | 55.4 M | ||
| Edgewise Therapeutics Inc | Sofinnova Ventures | 13.39 | 475,691 | 0.50% | NEW | 6.4 M | ||
| Exact Sciences Corp. | Sofinnova Ventures | 48.36 | 181,828 | 0.10% | -0.03 | 8.8 M | ||
| 4D Molecular Therapeutics Inc | Sofinnova Ventures | 4.24 | 271,155 | 0.52% | 0.14 | 1.1 M | ||
| Structure Therapeutics Inc - ADR | Sofinnova Ventures | 18.13 | 8,915 | 0.02% | 0.00 | 161.6 K | ||
| Idexx Laboratories, Inc. | Sofinnova Ventures | 520.87 | 63,862 | 0.08% | -0.01 | 33.3 M | ||
| Ideaya Biosciences Inc | Sofinnova Ventures | 21.81 | 1,151,528 | 1.33% | 0.40 | 25.1 M | ||
| Ikena Oncology Inc | Sofinnova Ventures | 1.27 | 382,616 | 0.79% | 0.55 | 485.9 K | ||
| Immunome Inc | Sofinnova Ventures | 10.82 | 655,680 | 1.05% | 0.06 | 7.1 M | ||
| Immatics N.V | Sofinnova Ventures | 5.85 | 796,704 | 0.67% | -1.43 | 4.7 M | ||
| Insmed Inc | Sofinnova Ventures | 102.78 | 227,747 | 0.13% | NEW | 23.4 M | ||
| Inspire Medical Systems Inc | Sofinnova Ventures | 125.14 | 10,000 | 0.03% | 0.01 | 1.3 M | ||
| Inhibrx Biosciences Inc. | Sofinnova Ventures | 22.12 | 463,315 | 3.20% | NEW | 10.2 M | ||
| Inozyme Pharma Inc | Sofinnova Ventures | 4.00 | 4,280,308 | 6.66% | -0.16 | 17.1 M | ||
| Disc Medicine Inc | Sofinnova Ventures | 59.38 | 29,256 | 0.10% | 0.08 | 1.7 M | ||
| Intuitive Surgical Inc | Sofinnova Ventures | 516.12 | 87,217 | 0.02% | -0.02 | 45.0 M | ||
| Kura Oncology Inc | Sofinnova Ventures | 6.47 | 825,243 | 1.06% | 0.40 | 5.3 M | ||
| Kyverna Therapeutics Inc. | Sofinnova Ventures | 3.87 | 47,850 | 0.11% | 0.09 | 185.2 K | ||
| LivaNova PLC | Sofinnova Ventures | 42.35 | 20,602 | 0.04% | 0.00 | 872.5 K | ||
| Masimo Corp | Sofinnova Ventures | 155.13 | 20,161 | 0.04% | 0.00 | 3.1 M | ||
| Madrigal Pharmaceuticals Inc | Sofinnova Ventures | 330.94 | 44,417 | 0.20% | 0.12 | 14.7 M | ||
| Marinus Pharmaceuticals Inc | Sofinnova Ventures | 0.55 | 4,151,576 | 7.52% | 4.97 | 2.3 M | ||
| Natera Inc | Sofinnova Ventures | 140.63 | 1,550,280 | 1.25% | -0.01 | 218.0 M | ||
| Novo Nordisk - ADR | Sofinnova Ventures | 64.92 | 649,541 | 0.01% | 0.00 | 42.2 M | ||
| Nextcure Inc | Sofinnova Ventures | 4.98 | 2,671,856 | 9.55% | 0.00 | 13.3 M | ||
| Phibro Animal Health Corp. - Ordinary Shares - Class A | Sofinnova Ventures | 29.14 | 237,009 | 0.59% | NEW | 6.9 M | ||
| PDS Biotechnology Corporation | Sofinnova Ventures | 1.15 | 142,635 | 0.39% | 0.00 | 164.0 K | ||
| PepGen Inc | Sofinnova Ventures | 1.32 | 561,128 | 1.72% | 0.17 | 740.7 K | ||
| Insulet Corporation | Sofinnova Ventures | 280.96 | 60,967 | 0.09% | -0.23 | 17.1 M | ||
| Rapport Therapeutics Inc. | Sofinnova Ventures | 14.39 | 1,951,562 | 5.34% | NEW | 28.1 M | ||
| Avidity Biosciences Inc | Sofinnova Ventures | 34.02 | 21,425 | 0.02% | NEW | 728.9 K | ||
| Soleno Therapeutics Inc | Sofinnova Ventures | 86.97 | 554,359 | 1.29% | 0.89 | 48.2 M | ||
| Syndax Pharmaceuticals Inc | Sofinnova Ventures | 9.73 | 2,153,669 | 2.53% | 0.63 | 21.0 M | ||
| Sarepta Therapeutics Inc | Sofinnova Ventures | 13.32 | 195,852 | 0.21% | -0.03 | 2.6 M | ||
| Savara Inc | Sofinnova Ventures | 2.29 | 5,358,918 | 3.14% | 1.71 | 12.3 M | ||
| Stryker Corp. | Sofinnova Ventures | 387.32 | 193,084 | 0.05% | NEW | 74.8 M | ||
| Teleflex Incorporated | Sofinnova Ventures | 109.79 | 13,649 | 0.03% | 0.00 | 1.5 M | ||
| TG Therapeutics Inc | Sofinnova Ventures | 37.42 | 1,861,277 | 1.19% | -0.09 | 69.6 M | ||
| Vera Therapeutics Inc - Ordinary Shares - Class A | Sofinnova Ventures | 22.79 | 2,793,987 | 4.51% | -0.59 | 63.7 M | ||
| Waters Corp. | Sofinnova Ventures | 281.66 | 21,804 | 0.04% | NEW | 6.1 M | ||
| Zimmer Biomet Holdings Inc | Sofinnova Ventures | 92.59 | 10,630 | 0.01% | NEW | 984.2 K | ||
| Mirum Pharmaceuticals Inc | 51.95 | - | Investor holds below 1% | |||||
| Cooper Companies, Inc. | 71.32 | - | Investor holds below 1% | |||||
| Argen X SE - ADR | 566.14 | - | Investor holds below 1% | |||||
| Merck & Co Inc | 79.31 | - | Investor holds below 1% | |||||
| Incyte Corp. | 67.38 | - | Investor holds below 1% |